Asia Pacific Embolization Coils Market

The Asia Pacific embolization coils market is expected to grow from US$ 267.89 million in 2022 to US$ 356.04 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028.

Mounting Applications of Embolization Coils

The increasing implementation of embolization coils in the embolotherapy for the treatment of endovascular disease, traumatic injuries, cerebrovascular malformation, venous malformation, arteriovenous malformation, and pediatric vascular conditions is expected to offer an opportunity for the embolization coils market revenue growth in the coming years. Embolization is a minimally invasive procedure to treat an aneurysm by packing it with material that closes the injured place and decreases the risk of bleeding. Embolization is performed within the artery (endovascular) through a steerable catheter inserted into the bloodstream and guided to the brain. Further, post-traumatic bleeding embolization is performed to stop bleeding caused by traumatic injuries. The method uses materials to block the affected vessel and stops blood flow. According to a Traumatic Brain Registry Surveillance Report 2021, a traumatic brain injury (TBI) is a disruption in a normal function of the brain that can be caused by a bump, blow, or jolt to the head or a penetrating head injury. Further, it has also been stated that TBIs are a major cause of death and disability, making these injuries a significant public health problem across the US. In Tennessee, ~24,382 TBI-related ED visits, hospitalizations, and deaths occurred during 2019. Thus, the rising adoption of embolization coils in various applications further increases the demand for embolization coils and supportive devices. Therefore, the growing adoption of embolization coils in embolotherapy is expected to boost the Asia Pacific embolization coils market growth opportunities in the upcoming forecast period.

Asia Pacific Embolization Coils Market Overview

The Asia Pacific embolization coils market segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The Asia Pacific region is expected to be the fastest growing region due to the increasing prevalence of chronic diseases, rising geriatric population, new product development, and international players entering the region. The incidences of the stroke have increased in the past years and the incidences of the abdominal aortic aneurysm has increased in the country. Therefore, the demands for the embolization coils are likely to increase in the coming future. Moreover, in China to meet the healthcare needs of the population the country has developed Healthy China 2030.

Asia Pacific embolization coils Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Embolization Coils Strategic Insights

Strategic insights for the Asia Pacific Embolization Coils provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Embolization Coils Report Scope

Asia Pacific Embolization Coils Regional Insights

The geographic scope of the Asia Pacific Embolization Coils refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Asia Pacific embolization coils market Segmentation

The Asia Pacific embolization coils market is segmented on the basis of type, material, application, end user, and country. Based on type, the Asia Pacific embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2022.

Based on material, the Asia Pacific embolization coils market is segmented into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2022.

Based on application, the Asia Pacific embolization coils market is segmented into neurology, cardiology, urology, oncology, peripheral vascular disease, and others. The neurology segment held the largest market share in 2022.

Based on end user, the Asia Pacific embolization coils market is segmented into hospital, cardiac center, ambulatory center, and other. The hospital segment held the largest market share in 2022.

Based on country, the Asia Pacific embolization coils market is segmented into the China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. The China dominated the market share in 2022.

Terumo Corporation; Medtronic; Boston Scientific Corporation; Stryker; KANEKA CORPORATION; MicroPort Scientific Corporation; Penumbra, Inc.; Cook Medical LLC; Johnson & Johnson Services, Inc.; and Shape Memory Medical INC. are the leading companies operating in the Asia Pacific embolization coils market.